Skip to content
10-Q

Quarterly Report

Monte Rosa Therapeutics, Inc. GLUE

0000950170-25-104550

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 61.76M sh
Shares Diluted Q2 2025 · Jun 30, 2025 82.19M sh
Shares Diluted Q2 2025 · Jun 30, 2025 82.89M sh
Shares Diluted Q2 2025 · Jun 30, 2024 71.23M sh
Shares Diluted Q2 2025 · Jun 30, 2024 65.7M sh
Dividends Paid Q2 2025 · Jun 30, 2025 $0
Capex Q2 2025 · Jun 30, 2025 $3.28M
Capex Q2 2025 · Jun 30, 2024 $3.41M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$80.21M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$65.93M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $69.43M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $224.25M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $108.85M
Stockholders Equity Q2 2025 · Jun 30, 2025 $268.08M
Stockholders Equity Q2 2025 · Mar 31, 2025 $275.16M
Stockholders Equity Q2 2025 · Dec 31, 2024 $222.94M
Stockholders Equity Q2 2025 · Jun 30, 2024 $224.67M
Stockholders Equity Q2 2025 · Mar 31, 2024 $152.52M
Stockholders Equity Q2 2025 · Dec 31, 2023 $179.25M
Current Liabilities Q2 2025 · Jun 30, 2025 $41.85M
Current Liabilities Q2 2025 · Dec 31, 2024 $156.95M
Total Liabilities Q2 2025 · Jun 30, 2025 $91.51M
Total Liabilities Q2 2025 · Dec 31, 2024 $215.8M
Current Assets Q2 2025 · Jun 30, 2025 $299.47M
Current Assets Q2 2025 · Dec 31, 2024 $377.44M
Total Assets Q2 2025 · Jun 30, 2025 $359.59M
Total Assets Q2 2025 · Dec 31, 2024 $438.73M
Sga Expense Q2 2025 · Jun 30, 2025 $8.1M
Sga Expense Q2 2025 · Jun 30, 2025 $16.8M
Sga Expense Q2 2025 · Jun 30, 2024 $9.28M
Sga Expense Q2 2025 · Jun 30, 2024 $18.27M
Rd Expense Q2 2025 · Jun 30, 2025 $30.65M
Rd Expense Q2 2025 · Jun 30, 2025 $62.84M
Rd Expense Q2 2025 · Jun 30, 2024 $28.06M
Rd Expense Q2 2025 · Jun 30, 2024 $55.08M
Net Income Q2 2025 · Jun 30, 2025 −$12.3M
Net Income Q2 2025 · Jun 30, 2025 $34.59M
Net Income Q2 2025 · Mar 31, 2025 $46.89M
Net Income Q2 2025 · Jun 30, 2024 −$30.31M
Net Income Q2 2025 · Jun 30, 2024 −$62.28M
Net Income Q2 2025 · Mar 31, 2024 −$31.97M
Operating Income Q2 2025 · Jun 30, 2025 −$15.55M
Operating Income Q2 2025 · Jun 30, 2025 $28.48M
Operating Income Q2 2025 · Jun 30, 2024 −$32.64M
Operating Income Q2 2025 · Jun 30, 2024 −$67.59M
Revenue Q2 2025 · Jun 30, 2025 $23.19M
Revenue Q2 2025 · Jun 30, 2025 $108.12M
Revenue Q2 2025 · Jun 30, 2024 $4.7M
Revenue Q2 2025 · Jun 30, 2024 $5.76M